LQDA
Price
$27.99
Change
+$0.26 (+0.94%)
Updated
Aug 27, 04:59 PM (EDT)
Capitalization
2.39B
76 days until earnings call
TPST
Price
$10.76
Change
-$0.21 (-1.91%)
Updated
Aug 27, 04:59 PM (EDT)
Capitalization
48.71M
Interact to see
Advertisement

LQDA vs TPST

Header iconLQDA vs TPST Comparison
Open Charts LQDA vs TPSTBanner chart's image
Liquidia
Price$27.99
Change+$0.26 (+0.94%)
Volume$31.95K
Capitalization2.39B
Tempest Therapeutics
Price$10.76
Change-$0.21 (-1.91%)
Volume$500
Capitalization48.71M
LQDA vs TPST Comparison Chart in %
Loading...
LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TPST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LQDA vs. TPST commentary
Aug 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LQDA is a StrongBuy and TPST is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 27, 2025
Stock price -- (LQDA: $27.73 vs. TPST: $10.97)
Brand notoriety: LQDA and TPST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LQDA: 110% vs. TPST: 79%
Market capitalization -- LQDA: $2.39B vs. TPST: $48.71M
LQDA [@Biotechnology] is valued at $2.39B. TPST’s [@Biotechnology] market capitalization is $48.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $99.27B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LQDA’s FA Score shows that 1 FA rating(s) are green whileTPST’s FA Score has 0 green FA rating(s).

  • LQDA’s FA Score: 1 green, 4 red.
  • TPST’s FA Score: 0 green, 5 red.
According to our system of comparison, LQDA is a better buy in the long-term than TPST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LQDA’s TA Score shows that 4 TA indicator(s) are bullish while TPST’s TA Score has 6 bullish TA indicator(s).

  • LQDA’s TA Score: 4 bullish, 4 bearish.
  • TPST’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, TPST is a better buy in the short-term than LQDA.

Price Growth

LQDA (@Biotechnology) experienced а +2.29% price change this week, while TPST (@Biotechnology) price change was +18.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.93%. For the same industry, the average monthly price growth was +13.93%, and the average quarterly price growth was +30.97%.

Reported Earning Dates

LQDA is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+3.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LQDA($2.39B) has a higher market cap than TPST($48.7M). LQDA YTD gains are higher at: 135.799 vs. TPST (1.120). TPST has higher annual earnings (EBITDA): -42.04M vs. LQDA (-133.4M). LQDA has more cash in the bank: 173M vs. TPST (14.3M). TPST has less debt than LQDA: TPST (8.66M) vs LQDA (200M). LQDA has higher revenues than TPST: LQDA (19.3M) vs TPST (0).
LQDATPSTLQDA / TPST
Capitalization2.39B48.7M4,901%
EBITDA-133.4M-42.04M317%
Gain YTD135.7991.12012,125%
P/E RatioN/AN/A-
Revenue19.3M0-
Total Cash173M14.3M1,210%
Total Debt200M8.66M2,309%
FUNDAMENTALS RATINGS
LQDA vs TPST: Fundamental Ratings
LQDA
TPST
OUTLOOK RATING
1..100
8427
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
52
Fair valued
PROFIT vs RISK RATING
1..100
11100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3539
P/E GROWTH RATING
1..100
10089
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TPST's Valuation (52) in the Pharmaceuticals Major industry is somewhat better than the same rating for LQDA (95). This means that TPST’s stock grew somewhat faster than LQDA’s over the last 12 months.

LQDA's Profit vs Risk Rating (11) in the Pharmaceuticals Major industry is significantly better than the same rating for TPST (100). This means that LQDA’s stock grew significantly faster than TPST’s over the last 12 months.

LQDA's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as TPST (100). This means that LQDA’s stock grew similarly to TPST’s over the last 12 months.

LQDA's Price Growth Rating (35) in the Pharmaceuticals Major industry is in the same range as TPST (39). This means that LQDA’s stock grew similarly to TPST’s over the last 12 months.

TPST's P/E Growth Rating (89) in the Pharmaceuticals Major industry is in the same range as LQDA (100). This means that TPST’s stock grew similarly to LQDA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LQDATPST
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 14 days ago
85%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TPST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ANVS2.430.19
+8.48%
Annovis Bio
LMGIF34.770.27
+0.78%
LUMINE GROUP INC.
OVHFF12.30N/A
N/A
OVH GROUPE
ARCO6.93-0.01
-0.14%
Arcos Dorados Holdings
FDMT6.53-0.21
-3.12%
4D Molecular Therapeutics

LQDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, LQDA has been loosely correlated with XNCR. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if LQDA jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LQDA
1D Price
Change %
LQDA100%
+5.64%
XNCR - LQDA
33%
Loosely correlated
-1.37%
CRNX - LQDA
32%
Poorly correlated
+2.79%
AXON - LQDA
32%
Poorly correlated
+0.72%
EXEL - LQDA
31%
Poorly correlated
+1.16%
TPST - LQDA
31%
Poorly correlated
+3.78%
More

TPST and

Correlation & Price change

A.I.dvisor indicates that over the last year, TPST has been loosely correlated with PHIO. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TPST jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TPST
1D Price
Change %
TPST100%
+3.78%
PHIO - TPST
49%
Loosely correlated
+2.51%
ABCZF - TPST
48%
Loosely correlated
N/A
LXEO - TPST
41%
Loosely correlated
+4.94%
ARCT - TPST
40%
Loosely correlated
-0.96%
RXRX - TPST
39%
Loosely correlated
N/A
More